Please login to the form below

Not currently logged in
Email:
Password:

Excellence in Creating Value Beyond the Pill

Back to categories

Judging criteria

Below is where the judges will be focusing their scores. Write your entries accordingly.

Excellence in creating market and customer insight (10)

  • Demonstrate how you gained in-depth understanding of the value that might be created beyond the product in line with stakeholder needs.

Clarity and appropriateness of objectives (10)

  • Demonstrate how your objectives related to all stakeholders and reinforced each other.

Quality of strategy development based on insights (15)

  • Evidence of resource allocation decisions designed to create value
  • Evidence of choices not to allocate resources.

Quality of execution (10)

  • Evidence as to how methods and tactics were based on the strategy
  • Evidence as to how methods and tactics reinforced each other
  • Evidence of organisational changes made to support strategy execution
  • Evidence of working with other stakeholders to support strategy execution and identify new opportunities.

Quality of measurement and learning (10)

  • Demonstrate how metrics have been applied to measure outcomes
  • Evidence of knowledge gained that will inform and shape future decision-making.

Evidence of value creation (15)

  • Evidence of improved clinical outcomes
  • Evidence of improved health economic outcomes
  • Evidence of other improved outcomes.

This award recognises excellence in work, conducted by any organisation involved in any market, whose aim was to improve clinical outcomes and/or health economic value that addressed stakeholder needs by methods other than the pharmaceutical therapy. These include, but are not restricted to:

  • The use of technology to make the use of a pharmaceutical therapy more clinically or economically effective, or both
  • The use of technology and services that improve the patient/clinical experience
  • Approaches to improving compliance or use of the product that lead to better clinical or health economic value, or both
  • Supporting healthcare systems in the delivery of services in a way that that leads to better clinical or health economic value, or both
  • The development and delivery of services delivered by the company in a way that that leads to better clinical or health economic value, or both.

Entries are invited from any individual, team, service or organisation that has improved clinical outcomes and/or health economic value by methods other than a pharmaceutical therapy. Judges will be looking for evidence of impact, sustainability and innovation.

Work conducted in the two-year period from July 2016 to June 2018 will be eligible.

SPONSORED BY:

Back to categories

Sponsors